
Investigation Report on China’s Omalizumab Markets, 2016-2020 & 2021-2025: Developed by Novartis Europharm – The Only Approved antibody designed to Target and Block Immunoglobulin E (IgE) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Omalizumab Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Omalizumab, developed by Novartis Europharm, is the only approved […]
